MILTENYI BIOMEDICINE
LIVE

Serial Number

79305056

Owner

MILTENYI BIOTEC B.V. & CO. KG

Attorney

Peter S. Sloane

Filing Date

Jul 13, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MILTENYI BIOMEDICINE Trademark

Serial Number: 79305056 • Registration: 6696088

MILTENYI BIOMEDICINE is a trademark filed by MILTENYI BIOTEC B.V. & CO. KG on July 13, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

MILTENYI BIOTEC B.V. & CO. KG (38 trademarks)

BERGISCH GLADBACH 51429 , DE

Entity Type: 30

Trademark Details

Filing Date

July 13, 2020

Registration Date

April 12, 2022

Published for Opposition

January 25, 2022

Goods & Services

Biological and biochemical storage, especially cryopreserved material for medical, scientific and biotechnological purposes

veterinary preparations for treatment of cancer, pharmaceutical preparations for the treatment of cancer; reagents, contrast media, materials and ingredients for the preparation of contrast media, all for medical or veterinary purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of material, especially of biological materials, reagents with magnetic beads, antibody reagents, all for medical or veterinary purposes; buffer solutions and reagents for use with medical instruments, especially separation instruments, analysis instruments, reactor and imaging instruments; reagents for the processing of biological material, especially tissue, bone marrow, cells, blood and its components, all for medical or veterinary purposes; culture media, cell culture media, diagnostic reagents and preparations for medical and veterinary purposes; freezing media, contrast agents, contrast agents for in-vivo imaging, all for medical and veterinary purposes; pharmaceutical products, especially pharmaceutical products in the nature of cell cultures and pharmaceutical preparations for cellular therapy; chemical, biological and biochemical preparations for therapeutic purposes for treatment of cancer; chemical, biological and biochemical diagnostic preparations for medical purposes; diagnostic contrast agents for medical use, contrast agents for in-vivo imaging for medical use

Plastic materials for packaging, namely, packaging bags for the cryopreservation of biological and biochemical material, especially cellular material for biological and medical research and therapy

industrial chemicals, biological preparations for use in cell cultures, other than for medical or veterinary purposes, biochemical preparations for scientific purposes; acetone for use in separation process for biological materials; reagents for cell separation, labeling reagents, reagents, cell culture media, substances and ingredients for the preparation of cell culture media, all for commercial and scientific purposes and for the use in medical laboratories; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of materials, especially of chemical and biological material for scientific and research use; reagents with magnetic beads for scientific and research use; antibody reagents other than for medical or veterinary purposes; buffer solutions and reagents for use with laboratory instruments, especially separation instruments, analysis instruments, reactors and imaging instruments; reagents for processing of biological material, especially tissue, bone marrow, cells, blood and its components other than for medical or veterinary purposes; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; culture media, cell culture media, freezing media, all for scientific purposes; reagents for use in biotechnology, in biological treatment processes and in the biotechnology industry other than for medical or veterinary purposes

Services of medical, pharmaceutical or biotechnological laboratories, namely, services of a medical and pharmaceutical laboratory, in particular in connection with the manufacture of cell therapeutic agents, cell compounds, cell preparation, cellular medicines, the selection, stimulation, activation of cells, as well as the manufacture of kits or reagents, medical services, in particular the field of extracorporeal plasma therapy; medical treatment services

Apparatus, namely, tubes for magnetic cell separation for medical purposes; tubing sets for cell separation for medical purposes; columns for magnetic cell separation for medical analysis cryogenic tubes and cryogenic freezing bags for medical purposes, in particular for cryopreservation; dialysis machines for medical use; apheresis machines for medical use; veterinary apparatus and instruments, namely, centrifugation devices; medical apparatus and instruments, namely, centrifugation devices

Scientific and technological services, namely, research and design of medical and laboratory equipment; industrial laboratory analysis and research services in the field of biology and medicine; design and development of computer hardware and software for the analysis of biological and biochemical material; all of the aforementioned services for and in connection with the analysis of biological and biochemical material, especially of cellular material for biological and medical research and therapy

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 15, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 15, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 15, 2025 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 20, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 26, 2022 FICS
FINAL DISPOSITION PROCESSED
Aug 25, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 12, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 12, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 25, 2022 PUBO
ASSIGNED TO EXAMINER
Jan 24, 2022 DOCK
NOTIFICATION PROCESSED BY IB
Jan 22, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 5, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 5, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 22, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 21, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 21, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 21, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 21, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 20, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 20, 2021 CRFA
ASSIGNED TO LIE
Dec 16, 2021 ALIE
NOTICE OF REVIVAL - E-MAILED
Dec 14, 2021 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 14, 2021 TROA
PETITION TO REVIVE-GRANTED
Dec 14, 2021 PETG
TEAS PETITION TO REVIVE RECEIVED
Dec 14, 2021 PROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 22, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 22, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 22, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 22, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 22, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 22, 2021 COAR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 1, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 1, 2021 ABN2
ASSIGNED TO EXAMINER
Oct 29, 2021 DOCK
REFUSAL PROCESSED BY IB
Mar 29, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 9, 2021 RFCS
APPLICATION FILING RECEIPT MAILED
Mar 9, 2021 MAFR
REFUSAL PROCESSED BY MPU
Mar 8, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 5, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 4, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 4, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 4, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 25, 2021 REPR